<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To verify that <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, which is caused by decreased glucuronidation capacity of the <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyl transferase (UGT)1A1, does not account for impaired <z:chebi fb="71" ids="17303">morphine</z:chebi> clearance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Noncompartmental pharmacokinetic parameters for <z:chebi fb="71" ids="17303">morphine</z:chebi> and its <z:chebi fb="0" ids="24302">glucuronide</z:chebi> metabolites were compared between five carriers of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and six noncarriers after a 7.5 mg (19.8 micro mol) intravenous injection of <z:chebi fb="71" ids="17303">morphine</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> pentahydrate </plain></SENT>
<SENT sid="2" pm="."><plain>To estimate the amount of <z:chebi fb="71" ids="17303">morphine</z:chebi>-6-<z:chebi fb="0" ids="24302">glucuronide</z:chebi> (M6G) formed from <z:chebi fb="71" ids="17303">morphine</z:chebi>, 1 mg of deuterized M6G was injected intravenously at the same time </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: No differences were detected between carriers and noncarriers of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in the clearance of <z:chebi fb="71" ids="17303">morphine</z:chebi> (80.1 +/- 12 l h(-1) vs 87.9 +/- 22 l h(-1)) and in the percentage of <z:chebi fb="71" ids="17303">morphine</z:chebi> that was metabolized to M6G (10.9 +/- 1.4 vs 13 +/- 2) </plain></SENT>
<SENT sid="4" pm="."><plain>The areas under the plasma concentration vs time curves of <z:chebi fb="71" ids="17303">morphine</z:chebi>, M6G and <z:chebi fb="71" ids="17303">morphine</z:chebi>-3-<z:chebi fb="0" ids="24302">glucuronide</z:chebi> also did not differ between carriers and noncarriers of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is not a factor to be considered when prescribing <z:chebi fb="71" ids="17303">morphine</z:chebi> </plain></SENT>
</text></document>